老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ascendis Pharma A/S

157.20
-4.3200-2.67%
盘前：163.516.31+4.01%08:56 EDT
成交量：28.71万
成交额：4,532.36万
市值：94.91亿
市盈率：-24.98
高：165.26
开：161.78
低：156.28
收：161.52
数据加载中...
总览公司新闻公告
2020/05/08

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/04/03

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/23

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多